The nuclear export protein XPO1—from biology to targeted therapy

AS Azmi, MH Uddin, RM Mohammad - Nature reviews Clinical oncology, 2021 - nature.com
Abstract Exportin 1 (XPO1), also known as chromosome region maintenance protein 1,
plays a crucial role in maintaining cellular homeostasis via the regulated export of a range of …

[HTML][HTML] Chemistry and pharmacology of fluorinated drugs approved by the FDA (2016–2022)

G Shabir, A Saeed, W Zahid, F Naseer, Z Riaz… - Pharmaceuticals, 2023 - mdpi.com
Fluorine is characterized by high electronegativity and small atomic size, which provide this
molecule with the unique property of augmenting the potency, selectivity, metabolic stability …

Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial

N Kalakonda, M Maerevoet, F Cavallo… - The Lancet …, 2020 - thelancet.com
Background Relapsed or refractory diffuse large B-cell lymphoma (DLBCL) is an aggressive
cancer with a median overall survival of less than 6 months. We aimed to assess the …

Small molecule inhibitors targeting the cancers

GH Liu, T Chen, X Zhang, XL Ma, HS Shi - MedComm, 2022 - Wiley Online Library
Compared with traditional therapies, targeted therapy has merits in selectivity, efficacy, and
tolerability. Small molecule inhibitors are one of the primary targeted therapies for cancer …

Mutant NPM1 maintains the leukemic state through HOX expression

L Brunetti, MC Gundry, D Sorcini, AG Guzman… - Cancer cell, 2018 - cell.com
NPM1 is the most frequently mutated gene in cytogenetically normal acute myeloid leukemia
(AML). In AML cells, NPM1 mutations result in abnormal cytoplasmic localization of the …

Clinical and molecular spectrum of liposarcoma

ATJ Lee, K Thway, PH Huang… - Journal of Clinical …, 2018 - ascopubs.org
Liposarcomas are rare malignant tumors of adipocytic differentiation. The classification of
liposarcomas into four principal subtypes reflects the distinct clinical behavior, treatment …

Inhibitors of nuclear transport

DA Jans, AJ Martin, KM Wagstaff - Current opinion in cell biology, 2019 - Elsevier
Central to eukaryotic cell function, transport into and out of the nucleus is largely mediated
by members of the Importin (IMP) superfamily of transporters of α-and β-types. The first …

Selective inhibition of nuclear export with oral selinexor for treatment of relapsed or refractory multiple myeloma

DT Vogl, D Dingli, RF Cornell, CA Huff… - Journal of clinical …, 2018 - ascopubs.org
Purpose Selinexor, a first-in-class, oral, selective exportin 1 (XPO1) inhibitor, induces
apoptosis in cancer cells through nuclear retention of tumor suppressor proteins and the …

The intersection of COVID-19 and cancer: signaling pathways and treatment implications

Z Zong, Y Wei, J Ren, L Zhang, F Zhou - Molecular cancer, 2021 - Springer
The outbreak of the novel coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a serious public health …

A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia

R Garzon, M Savona, R Baz, M Andreeff… - Blood, The Journal …, 2017 - ashpublications.org
Selinexor is a novel, first-in-class, selective inhibitor of nuclear export compound, which
blocks exportin 1 (XPO1) function, leads to nuclear accumulation of tumor suppressor …